Michael J. Hoy

Overview

Michael J. Hoy is an Australian investor and director with over 30 years of corporate experience across Australia, the United Kingdom, the United States, and Asia. He currently serves as the Independent and Non-Executive Chairman of Biotron Limited, a biotechnology company focused on antiviral therapies targeting unmet medical needs. Mr. Hoy has been with Biotron since 2000, initially joining as a director and later assuming the role of chairman in 2000. He is also the Chairman of Lipotek Pty Limited, a pharmaceutical company, and has held various leadership positions in other organizations, including Telesso Technologies Limited and CityPrint Holdings Pty Limited. His extensive background in the biotechnology and pharmaceutical sectors underscores his expertise in these industries. Throughout his career, Mr. Hoy has been involved in strategic decision-making and corporate governance, contributing to the growth and development of the companies he has led. His leadership roles have encompassed both executive and non-executive positions, reflecting his versatility and depth of experience in the corporate world. His tenure at Biotron Limited, in particular, highlights his commitment to advancing antiviral research and development. Mr. Hoy's professional journey is marked by a focus on innovation and strategic growth within the biotechnology and pharmaceutical sectors. His leadership has been instrumental in steering companies through various stages of development, from early-stage ventures to established entities. His ability to navigate complex corporate landscapes and drive business success is a testament to his expertise and dedication to the industries he serves.

Investment Focus

• Focus on biotechnology and pharmaceutical sectors
• Interest in companies with innovative research and development
• Preference for investments in Australia, the United Kingdom, the United States, and Asia
• Willingness to engage in both early-stage and growth-stage investments

Portfolio Companies